logo

For the Inventor, By the Inventor

Jersey City, NJ, United States of America

Golden Biotechnology Corporation


USPTO Granted Patents = 20

% Expired Patents = 15.0



Trademarks = 4

Forward Citations = 53

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Wu-Che Wen (14 out of 14 patents)

silverMedal Sheng-Yung Liu (13 out of 13 patents)

bronzeMedal Chih-Ming Chen (9 out of 213 patents)

4.  Sheng-Yun Liu (7 out of 7 patents)

5.  Mao-Tien Kuo (7 out of 7 patents)

6.  San-Bao Hwang (2 out of 2 patents)

7.  Hsiu-Yi Cheng (1 out of 1 patent)

8.  Yu-Lung Wang (1 out of 1 patent)

9.  San-Bao Huang (1 out of 1 patent)

10.  Wan-Ling Tsou (1 out of 1 patent)

11.  Chun-Hung Huang (1 out of 1 patent)

12.  Ka-Hang Fok (1 out of 1 patent)

13.  Ya-Ying Li (1 out of 1 patent)

14.  Chun-Chou Chang (1 out of 1 patent)

15.  Hao-Yu Cheng (1 out of 1 patent)


20 patents:

1. 11786485 - Methods and compositions for treating advanced stage non-small cell lung cancer (2023-10-17),
2. 11406605 - Therapeutic compositions for treating pancreatic cancer (2022-08-09),
3. 11364209 - Methods and compositions for treating atopic dermatitis (2022-06-21),
4. 10959963 - Method for the treatment of fatty liver disease (2021-03-30),
5. 10905656 - Methods and compositions for treating arteriosclerotic vascular diseases (2021-02-02),
6. 10858307 - Compositions and methods for treating liver cancer (2020-12-08),
7. 10406120 - Methods and compositions for treating kidney disorders (2019-09-10),
8. 9861592 - Methods and compositions for treating neurodegenerative diseases (2018-01-09),
9. 9403747 - Methods and compositions for treating leukemia (2016-08-02),
10. 9365481 - Cyclohexenone compositions and process for making thereof (2016-06-14),
11. 8648117 - Methods and compositions for treating cancer metastasis (2014-02-11),
12. 8309611 - Methods and compositions for treating lung cancer (2012-11-13),
13. 8236860 - [object Object] (2012-08-07),
14. 7749546 - Composition for effectively suppressing the growth of prostate cancer cell, suppressing the prostatic hyperplasia and its preparation method (2010-07-06),
15. 7501454 - [object Object] (2009-03-10),
Company Overview
Golden Biotechnology Corporation is a biopharmaceutical company based in Jersey City, NJ, specializing in the development and commercialization of innovative therapies. The organization focuses on advancing treatments in various therapeutic areas, leveraging cutting-edge research and technology to address unmet medical needs. With a commitment to enhancing patient outcomes, Golden Biotechnology engages in extensive research initiatives and collaborations to drive the discovery of novel solutions in the biotechnology landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#11 in Jersey City, NJ

#619 in New Jersey

#16,395 in US

#31,264 in the World

Jersey City, NJ (US)
Jersey City, NJ, United States of America

Golden Biotechnology Corporation

Forward Citations = 53

16 inventors:

goldMedal Wu-Che Wen (14 out of 14 patents)

silverMedal Sheng-Yung Liu (13 out of 13 patents)

bronzeMedal Chih-Ming Chen (9 out of 213 patents)

4.  Sheng-Yun Liu (7 out of 7 patents)

5.  Mao-Tien Kuo (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Golden Biotechnology Corporation. Retrieved from https://idiyas.com/company/golden-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…